Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-90,126
Closed -$1.77M 2588
2017
Q1
$1.77M Buy
90,126
+5,360
+6% +$101K ﹤0.01% 1221
2016
Q4
$1.36M Sell
84,766
-269
-0.3% -$3.72K ﹤0.01% 1326
2016
Q3
$1.06M Hold
85,035
﹤0.01% 1419
2016
Q2
$835K Buy
85,035
+75,885
+829% +$779K ﹤0.01% 1494
2016
Q1
$114K Buy
9,150
+6,319
+223% +$67K ﹤0.01% 1713
2015
Q4
$35K Hold
2,831
﹤0.01% 2263
2015
Q3
$41K Hold
2,831
﹤0.01% 2163
2015
Q2
$35K Hold
2,831
﹤0.01% 2352
2015
Q1
$34K Hold
2,831
﹤0.01% 2227
2014
Q4
$32K Hold
2,831
﹤0.01% 2247
2014
Q3
$26K Hold
2,831
﹤0.01% 2259
2014
Q2
$32K Hold
2,831
﹤0.01% 2134
2014
Q1
$35K Hold
2,831
﹤0.01% 1978
2013
Q4
$38K Buy
+2,831
New +$39.4K ﹤0.01% 1940

Other funds holding XXIA

Canada Life's XXIA Position: Q2 2017 in Review

Canada Life sold out of Ixia (XXIA) in Q2 2017, closing a stake of 90,126 shares — an estimated $1.77M sold.

Canada Life first reported a position in XXIA in Q4 2013 and held it in 14 quarters. The position peaked at $1.77M in Q1 2017. 1 fund tracked by Wall St. Rank holds XXIA as of Q2 2017.

  • Canada Life reported no remaining Ixia position as of Q2 2017 after selling out during the quarter.
  • Canada Life sold 90,126 Ixia shares in Q2 2017, an estimated $1.77M.
  • Canada Life first reported a position in Ixia in Q4 2013 and held it in 14 quarters.
  • Canada Life's Ixia position peaked at $1.77M in Q1 2017.
  • 1 fund tracked by Wall St. Rank held Ixia as of Q2 2017.

Based on Canada Life's 13F filing for Q2 2017, filed 27 Jul 2017.